ClinicalTrials.Veeva

Menu

Improving Physical Health in Patients With Psychiatric Disorders in General Practice (SOFIA)

University of Copenhagen logo

University of Copenhagen

Status

Completed

Conditions

Psychiatric Disorder
Schizophrenia
Bipolar Disorder
Severe Depression

Treatments

Other: SOFIA model

Study type

Interventional

Funder types

Other

Identifiers

NCT04618250
NNF16OC0022038

Details and patient eligibility

About

People with a severe mental illness (SMI) have an increased risk for premature mortality, predominantly due somatic health conditions. Evidence indicates that prevention and improved treatment of somatic conditions in patients with SMI could reduce this excess mortality. This paper reports a protocol designed to evaluate the feasibility and acceptability of a coordinated co-produced care programme (SOFIA model) in the general practice setting to reduce mortality and improve quality of life in patients with severe mental illness. The primary outcomes are description of study feasibility (recruitment and retention) and acceptability.

The SOFIA trial is designed as cluster randomized controlled trial targeting general practices in two regions in Denmark. 12 practices will each recruit 15 community-dwelling patients aged 18 and older with severe mental illness (SMI). Practices will be randomized in a ratio 2:1 to deliver a coordinated care program or care-as-usual during a 6 month period. An online randomized algorithm is used to perform randomization. The coordinated care program comprises enhanced educational training of general practitioners and their clinical staff, and prolonged consultations focusing on individual needs and preferences of the patient with SMI. Assessments are administered at baseline, and at end of study period.

If delivery of the intervention in the general practice setting proves feasible, a future definitive trial to determine the effectiveness of the intervention in reducing mortality and improving quality of life in patients with SMI can take place.

Enrollment

76 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Registered at a general practice situated in the Danish Capital Region or the Region of Zealand;
  • Registered at general practice with International Classification of Primary Care version 2 (ICPC-2) diagnostic code p72 (psychotic disorders);
  • Registered at general practice with ICPC-2 diagnostic code p73 (bipolar mood disorders);
  • Prescription of Lithium (Anatomical Therapeutic Chemical (ATC): N05AN);
  • Registered at general practice with ICPC-2 diagnostic code p76 AND (Prescription of Lamotrigine (N03A09) OR Carbamazepine (N03AF01) OR Valproic Acid (N03AG01));
  • Registered at general practice with ICPC-2 diagnostic code p76 (unipolar depressive disorders) AND (Prescription of tricyclic antidepressants (N06AA) AND/OR venlafaxine (N06AX16) AND/OR duloxetine (N06AX21) AND/OR Monoamine Oxidase A Inhibitor (MAOi) (N06AG) AND/OR non-selective MAOi (N06AF)).

Exclusion criteria

  • Subjected to any type of legal measure as stipulated in the Danish Mental Health Law;
  • Registered with a dementia diagnosis ICPC-2 p70 (dementia);
  • Receiving end-of-life care;
  • Non-Danish speakers;
  • Assumed by the patient's general practitioner to have an overall functional level that is too low for meaningful participation in trial.

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

76 participants in 2 patient groups

Coordinated, co-produced health care
Experimental group
Treatment:
Other: SOFIA model
Care as usual
No Intervention group
Description:
Care as usual

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems